aspirin and 11-dehydro-2,3-dinor-thromboxane b2

aspirin has been researched along with 11-dehydro-2,3-dinor-thromboxane b2 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alberti, E; Bonollo, M; Chiabrando, C; Djurup, R; Fanelli, R; Rivoltella, L	1
Becker, DM; Becker, LC; Bray, PF; Fallin, MD; Faraday, N; Herrera-Galeano, JE; Mathias, R; Moy, TF; Vaidya, D; Wilson, AF; Yanek, LR	1
Anzellotti, P; Capone, ML; Di Francesco, L; Di Gregorio, P; Merciaro, G; Patrignani, P; Sciulli, MG; Tacconelli, S	1

Trials

1 trial(s) available for aspirin and 11-dehydro-2,3-dinor-thromboxane b2

Article	Year
Human pharmacology of naproxen sodium. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Lipopolysaccharides; Monocytes; Naproxen; Platelet Aggregation; Thromboxane B2	2007

Article

Year

Human pharmacology of naproxen sodium.

The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2

Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Lipopolysaccharides; Monocytes; Naproxen; Platelet Aggregation; Thromboxane B2

2007

Other Studies

2 other study(ies) available for aspirin and 11-dehydro-2,3-dinor-thromboxane b2

Article	Year
Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. Prostaglandins, 1993, Volume: 45, Issue:5 Topics: Adult; Aspirin; Blood Platelets; Humans; Male; Reference Values; Smoking; Thromboxane B2; Thromboxanes	1993
Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Circulation, 2007, May-15, Volume: 115, Issue:19 Topics: Adult; Arachidonic Acid; Aspirin; beta-Thromboglobulin; Black or African American; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Resistance; Dyslipidemias; Female; Genetic Heterogeneity; Genetic Predisposition to Disease; Genetic Variation; Humans; Hyperglycemia; Hypertension; Male; Membrane Proteins; Middle Aged; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Sex Characteristics; Smoking; Thrombophilia; Thrombosis; Thromboxane B2; White People	2007

Article

Year

Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.

Prostaglandins, 1993, Volume: 45, Issue:5

Topics: Adult; Aspirin; Blood Platelets; Humans; Male; Reference Values; Smoking; Thromboxane B2; Thromboxanes

1993

Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.

Circulation, 2007, May-15, Volume: 115, Issue:19

Topics: Adult; Arachidonic Acid; Aspirin; beta-Thromboglobulin; Black or African American; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Resistance; Dyslipidemias; Female; Genetic Heterogeneity; Genetic Predisposition to Disease; Genetic Variation; Humans; Hyperglycemia; Hypertension; Male; Membrane Proteins; Middle Aged; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Sex Characteristics; Smoking; Thrombophilia; Thrombosis; Thromboxane B2; White People

2007